Rocket Lab Is Up Nearly 250% in a Year. Is This the 1 Space Stock You Buy on Every Dip and Never Sell?

Rocket Lab reported record 2025 revenue of $602 million, up 38% year over year, while backlog jumped 73% to nearly $1.9 billion and missions last year reached 21 with a 100% success rate. The key catalyst is Neutron, its upcoming medium-lift rocket that could compete with SpaceX's Falcon 9, but the company remains unprofitable with nearly $200 million in losses and shares trading at about 66x sales. The stock has surged nearly 250% over the past year, so much of the expected future success is already priced in.

Analysis

RKLB is transitioning from a “story stock” to a leveraged call option on execution, but the market is already paying for a high probability of success. The second-order dynamic is that the current valuation effectively assumes Neutron becomes not just functional, but commercially reliable fast enough to convert backlog into repeatable, high-margin cadence; in space launch, the gap between first flight and bankable fleet economics is usually measured in quarters to years, not weeks.

The biggest underappreciated winner is not necessarily RKLB’s equity holder set today, but its customers and ecosystem if Neutron works: defense primes and satellite operators gain a credible second source to SpaceX, which should improve procurement optionality and pricing leverage across the launch stack. That same dynamic can pressure smaller launch peers and new entrants by raising the bar for capital intensity, reliability, and mission density—this is a winner-take-most market where credibility compounds faster than capacity.

The key risk is a valuation-air-pocket if any Neutron milestone slips, because the stock has little room for “good but not perfect” execution. In the next 3–9 months, the name will likely trade more on program updates and cadence signals than on near-term revenue, so even minor delays can compress multiple sharply before fundamentals catch up. The contrarian read is that consensus is treating backlog like revenue visibility, but for aerospace that conversion rate is the whole bet; if launch cadence or unit economics disappoint, the market will re-rate RKLB as a profitable systems vendor in waiting rather than a platform winner.

The most attractive setup is a tactical, event-driven structure rather than a plain long. If you want exposure, own it through defined-risk upside or a starter position sized for binary program risk, and be prepared to add only after evidence of Neutron reliability, not before. If execution slips, the downside can be rapid because the stock’s current multiple leaves no cushion for schedule drift.

Key Decisions for Investors

• Prefer a small starter long in RKLB only ahead of concrete Neutron milestones; size as a speculative 6–9 month catalyst trade, not a core holding, because the stock is already pricing a near-flawless path.
• Buy RKLB call spreads 6–12 months out instead of common stock to express upside with defined downside; best if you want convexity into Neutron without owning full multiple-compression risk.
• If RKLB rallies on rumor rather than verified launch progress, fade strength with a short-dated put spread; the setup is vulnerable to a sharp 15–25% drawdown on any schedule slip.
• Monitor defense-space proxies for relative value: long RKLB only if launch-readiness improves faster than peers like ASTS/Redwire-type supply-chain names; otherwise, avoid chasing the headline beta.
• Use any post-catalyst pop to trim 30–50% of exposure unless Neutron has demonstrated repeatable reliability; at this valuation, the market will reward proof more than promise.